로딩 중…
StockDiggingStockDigging

Integra LifeSciences Holdings Corporation

IART· NASDAQ
$15.22+0.79%
2026-09-18

Financials

Valuation Metrics

Integra LifeSciences Holdings Corporation's Market Cap is $1.18B. At end of 2025 it was $953M. Ranked #2378 of 3,121 in US market (top 76%), #962 of 1,463 on NASDAQ (top 66%), #148 of 205 in Health Care Equipment & Services (top 72%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$1.18B
Revenue$1.65B
Net Income$-7M
Total Assets$3.59B
Net Assets$1.05B
Employees4,427
Value
P/B1.13x
P/S0.72x
EV/EBITDA12.09x
FCF Yield3.27%
Profitability
ROE-0.69%
ROA-0.20%
Op. Margin39.81%
Revenue Growth1.60%
Financial Health
Debt Ratio241.29%
Total Debt$2.04B
FCF$39M
Cash$214M
Current Ratio3.40x
Net Debt/EBITDA7.34x
Dividend
Div. Yield0.00%
Payout Ratio0.00%
Performance
1Y Return-1.04%
1M Return-11.72%
From 52W High-25.72%
1Y MDD-44.79%
Trading
Volume1,768,575 shares
Trading Value$27M
Per Share
EPS$-0.09
BPS$13.51

Company Info

CEO Ms. Mojdeh Poul
Employees 4,427
HQ Princeton, United States

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.